Loading...
Repligen Corporation
RGEN•NASDAQ
Healthcare
Medical - Instruments & Supplies
$121.73
$-0.14(-0.11%)
Repligen Corporation (RGEN) Financial Performance & Income Statement Overview
Review Repligen Corporation’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
0.33%
↑ 0.33%
Operating Income Growth
-173.61%
↓ 173.61%
Net Income Growth
-171.68%
↓ 171.68%
Operating Cash Flow Growth
53.97%
↑ 53.97%
Operating Margin
-5.62%
↓ 5.62%
Gross Margin
42.72%
↑ 42.72%
Net Profit Margin
-3.93%
↓ 3.93%
ROE
-1.27%
↓ 1.27%
ROIC
-1.34%
↓ 1.34%
Repligen Corporation (RGEN) Income Statement & Financial Overview
Review Repligen Corporation's (RGEN) income statement with detailed quarterly and annual figures.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $167.55M | $154.87M | $154.07M | $151.35M |
| Cost of Revenue | $83.09M | $77.38M | $85.30M | $76.39M |
| Gross Profit | $84.45M | $77.49M | $68.77M | $74.95M |
| Gross Profit Ratio | $0.50 | $0.50 | $0.45 | $0.50 |
| R&D Expenses | $11.68M | $9.71M | $10.57M | $11.24M |
| SG&A Expenses | $56.63M | $73.94M | $64.70M | $60.99M |
| Operating Expenses | $120.95M | $85.32M | $75.27M | $72.22M |
| Total Costs & Expenses | $204.05M | $162.70M | $152.59M | $148.62M |
| Interest Income | -$411000.00 | $0.00 | $0.00 | $0.00 |
| Interest Expense | $5.46M | $0.00 | $5.50M | $4.89M |
| Depreciation & Amortization | $17.40M | $17.42M | $16.76M | $16.79M |
| EBITDA | $33.71M | $21.39M | $27.44M | $18.82M |
| EBITDA Ratio | $0.20 | $0.14 | $0.18 | $0.12 |
| Operating Income | -$36.50M | -$7.83M | $1.49M | $2.03M |
| Operating Income Ratio | -$0.22 | -$0.05 | $0.010 | $0.01 |
| Other Income/Expenses (Net) | -$2.11M | $6.68M | $3.69M | $83000.00 |
| Income Before Tax | -$38.61M | -$1.15M | $5.18M | $2.11M |
| Income Before Tax Ratio | -$0.23 | -$0.007 | $0.03 | $0.01 |
| Income Tax Expense | -$4.74M | -$495000.00 | $1.86M | $20000.00 |
| Net Income | -$33.87M | -$654000.00 | $3.32M | $2.09M |
| Net Income Ratio | -$0.20 | -$0.004 | $0.02 | $0.01 |
| EPS | -$0.60 | $0.32 | $0.06 | $0.04 |
| Diluted EPS | -$0.60 | $0.32 | $0.06 | $0.04 |
| Weighted Avg Shares Outstanding | $56.06M | $56.01M | $55.88M | $55.79M |
| Weighted Avg Shares Outstanding (Diluted) | $56.06M | $56.94M | $56.43M | $56.53M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan